Dental Management of Patients with Bone Marrow and Solid Organ Transplantation

Dental Clinics of North America

Volumn 50, Issue 4, 2006, Pages 659-676

  Goldman, Kim E ^a,b  

^a PLC   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW TRANSPLANTATION; DENTAL CARE; DISEASE PREDISPOSITION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MOUTH HYGIENE; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; REVIEW;

BONE MARROW TRANSPLANTATION; DENTAL CARE FOR CHRONICALLY ILL; DISEASE SUSCEPTIBILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; OPPORTUNISTIC INFECTIONS; ORAL HYGIENE; ORGAN TRANSPLANTATION; TRANSPLANTATION CONDITIONING;

EID: 33748803358     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2006.06.009     Document Type: Review

References (25)

1. Hariharan S., Johnson C.P., Bresnahan B.A., et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342 (2000) 605-612
2. United Network for Organ Sharing. Available at: http://www.UNOS.org.
3. Cutler C., and Antin J.H. An overview of hematopoietic stem cell transplantation. Clin Chest Med 26 (2005) 517-527
4. Flomenberg N., Baxter-Lowe L.A., Confer D., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 104 (2004) 1923-1930
5. Krishnan A., Bhatia S., Slovak M.L., et al. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood 95 (2000) 1588-1593
6. Metayer C., Curtis R.E., Vose J., et al. Myelodysplastic syndrome and cute myeloid leukemia after autotransplantation for lymphoma: a multi-center case-control study. Blood 101 (2003) 2015-2023
7. Ho V.T., and Soiffer R.J. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 98 (2001) 3192-3204
8. Storek J., Jsoeph A., Espino G., et al. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood 102 (2003) 2768-2776
9. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351 (2004) 2265-2275
10. Storek J., Dawson M.A., Storer B., et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97 (2001) 3380-3389
11. Ottinger H.D., Beelen D.W., Scheulen B., et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88 (1996) 2775-2779
12. Socie G., Stone J.V., Wingard J.R., et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med 341 (1999) 14-21
13. Nevill T.J., Sheperd J.D., Nantel S.H., et al. Stem cell transplant-related mortality (TRM) 1985-1996: the Vancouver experience. [Abstract 4426]. Blood 90 10 (1997) (Suppl 1 [part 2 of 2]):373b
14. Kernan N.A., Bartsch G., Ash R.C., et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328 9 (1993) 593-602
15. Centers for Disease Control. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Morb Mortal Wkly Rep 49 RR-10 (2000) 1-128
16. Hurst P. Dental issues before and after organ transplantation. In: Stuart F.P., Abecassis M.M., and Kaufman D.B. (Eds). Organ transplantation (2000), Landes Bioscience, Georgetown (TX) 517-522
17. Guggenheim J., Egthesad B., and Stock D.J. Dental management of the (solid) organ transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 (2003) 383-389
18. Meyer U., Weingart D., Deng M.C., et al. Heart transplants-assessment of dental procedures. Clin Oral Investig 3 (1999) 79-83
19. Tolkoff-Rubin NE, Rubin RH. Infection in solid organ transplantation. In: Cohen, Powderly. Infectious diseases. 2nd edition. 2004. p. 1099-107.
20. The U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. Annual report 2004. Chapter IV. Immunosuppresion: evolution in practice and trends, 1993-2003. Available at: =http://www.ustransplant.org/annual_reports/archives/2004/Chapter_IV_AR_CD.htm?cp=5. Accessed June 27, 2006.
21. Casiglia J., and Woo S.B. Oral hairy leukoplakia as an early indicator of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder. J Oral Maxillofac Surg 60 (2002) 948-950
22. Hernandez G., Jimenez C., Arriba L., et al. Resolution of oral ulcerations after decreasing the dosage of tacrolimus in a liver transplantation recipient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 (2001) 526-531
23. Demarosi F., Soligo D., Lodi G., et al. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100 (2005) 63-69
24. Bez C., Demarosi F., Sardella A., et al. GM-CSF mouthrinses in the treatment of severe oral mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 (1999) 311-315
25. Epstein J.B., Gorsky M., and Caldwell J. Fluconazole mouthrinses for oral candidiasis in post-irradiation, transplant and other patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 (2002) 671-675